Aclaris Therapeutics (0H8T.LSE) Q2 2024 Earnings

7MayConfirmed
Q2 2024
-0.29
-0.27
-0.26
-0.24

Details

Expected EPS
-0.285714
Actual EPS
-0.24
Surprise EPS
0.05
Surprise Percent
+16%

Description

Aclaris Therapeutics (0H8T.LSE) has reported earnings of -0.24 per share for Q2 2024.

0 Comments

Share your thoughts